Lexatumumab

• Description:

  Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleural mesothelioma (MPM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  143.6 (kDa)

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis

• CAS Number:

  845816-02-6